SCHEDULE: L1 Capital Boosts Healthcare Triangle Stake
Beneficial Ownership Report
L1 Capital Global Opportunities Master Fund, Ltd. has increased its beneficial ownership in Healthcare Triangle, Inc. to 0.35% of common stock.
Summary
- L1 Capital Global Opportunities Master Fund, Ltd. filed an Amendment No. 1 to its Schedule 13G regarding its beneficial ownership in Healthcare Triangle, Inc.
- The fund beneficially owns 1,417,420 shares of Healthcare Triangle, Inc. common stock.
- This ownership represents 0.35% of the total outstanding common stock.
- The beneficial ownership includes 464,681 shares of common stock issued upon conversion of $200,000 principal amount of a Senior Secured 15% Original Issue Discount Convertible Promissory Note.
- Additionally, the ownership includes 595,239 shares and 357,500 shares underlying warrants.
- The percentage of class is calculated based on 408,445,597 shares of common stock outstanding as of May 19, 2025, as reported in Healthcare Triangle, Inc.'s Quarterly Report on Form 10-Q filed on May 20, 2025.
- The reporting person's beneficial ownership is limited to 9.9% due to existing limitations, even if a dispute regarding anti-dilution protection were resolved within 60 days.
Sentiment
Score: 5
Explanation: A Schedule 13G is a neutral, factual disclosure of beneficial ownership. It does not inherently convey positive or negative sentiment regarding the issuer's performance, though an increase in ownership by an institutional investor can sometimes be perceived as a positive signal.
Positives
- NA
Negatives
- NA
Risks
- Beneficial ownership limitation: The reporting person's beneficial ownership is capped at 9.9% due to existing limitations, irrespective of the resolution of any anti-dilution protection disputes.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership by an investment fund in a healthcare technology company. It does not provide broader industry trends or competitive analysis.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- The reporting person is engaged in discussions regarding anti-dilution protection, implying a potential dispute or negotiation related to the terms of their investment.
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The disclosure provides transparency regarding a significant institutional investor's stake, which can influence market perception and liquidity.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2025-02-03 | Date of purchase of 464,681 shares of Common Stock and underlying Warrants mentioned in the initial Schedule 13G. |
| 2025-02-04 | Date of initial Schedule 13G filing with the Securities and Exchange Commission. |
| 2025-05-19 | Date as of which 408,445,597 shares of Common Stock were outstanding, based on the Issuer's Quarterly Report on Form 10-Q. |
| 2025-05-20 | Date Healthcare Triangle, Inc. filed its Quarterly Report on Form 10-Q. |
| 2025-08-14 | Date of event requiring the filing of this statement and the signature date of the Schedule 13G/A. |
Keywords
Healthcare Triangle, L1 Capital, Schedule 13G, Beneficial Ownership, Common Stock, Convertible Note, Warrants, SEC Filing, Investment Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.